Psychosis represents a state of accelerated or disordered aging across multiple physiological systems rather than a discrete psychiatric illness. This reframing has direct implications for longevity interventions, suggesting that addressing the underlying systemic dysregulation—rather than targeting symptoms alone—may alter trajectories of both mental and physical health.
Key Points
- Psychosis correlates with accelerated aging biomarkers across systems
- Systemic dysregulation precedes and underlies psychotic symptom emergence
- Multisystem intervention may arrest or reverse aging-related trajectories
Longevity Analysis
The evidence that psychosis reflects aberrant aging across circulation, energy production, inflammation, and neurological function challenges the conventional symptom-management approach. Rather than treating psychosis as a contained psychiatric condition, this framework points toward identifying and correcting the upstream systemic failures—whether in metabolic regulation, mitochondrial function, vascular integrity, or nervous system coherence—that allow accelerated aging to manifest as cognitive and perceptual breakdown. Practitioners working in longevity medicine can apply this insight by screening for the same physiological markers of premature aging in patients presenting with psychotic features, enabling early intervention at the system level before irreversible damage accumulates.
Original published by Nature - npj Aging, by Rachel Upthegrove.